Nov 20, 2013
Lytix Biopharma's drug candidate LTX-315 presented at AASLD in Washington

Aftenposten online writes about Lytix Biopharma's drug candidate LTX-315 and the presentation at AASLD.

http://www.aftenposten.no/helse/Haper-pa-gjennombrudd-for-behandling-av-leverkreft-7361559.html